Location of Repository

Incentivizing the Utilization of Pharmacogenomics in Drug Development

By Valerie Gutmann Koch
Topics: pharmacogenomics, drug development, designer drugs, adverse drug reaction, pharmaceutical companies, orphan drug, Food and Drug Administration, FDA, Orphan Drug Act, ODA, liability, Chemicals and Drugs, Health Law and Policy
Publisher: DigitalCommons@UM Carey Law
Year: 2012
OAI identifier: oai:digitalcommons.law.umaryland.edu:jhclp-1196
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://digitalcommons.law.umar... (external link)
  • http://digitalcommons.law.umar... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.